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Previewsand finally access DICER1. Elucidating
this process is critical to our under-
standing of the pathology associated to
visceral leishmaniasis.
It is important to point out that, although
absence of miRNP-122 in liver results in
diminished serum cholesterol due to
decreased synthesis of HMGCoA re-
ductase, this also leads to augmented
cytoplasmic triglyceride accumulation
through upregulation of FSP27 (Wen and
Friedman, 2012). This protein, a direct
target of miR-122, is a negative regulator
of lipolysis and promotes triglyceride build
up. Hence, it is possible that increased
FSP27 in Leishmania-infected liver could
promote triglyceride accumulation and
gradual steatohepatitis. Furthermore,
miR-122absence results in liver inflamma-
tion, increased cytokine secretion, and
carcinogenesis. This raises the intriguing
possibility that GP63-mediated cleavage
of DICER1 could play a primordial role in
hepatocyte-mediated liver inflammation.
Though the authors clearly showed
that reconstitution of miR-122 or DICER1vastly decreases parasite burden, cleav-
age of DICER1 certainly has a more pro-
found impact on liver pathology. DICER1
regulates the maturation of a panoply of
miRNAs that also modulate liver homeo-
stasis and function. For example, it
would be of interest to elucidate the
effect of Leishmania on miR-33, which
regulates cholesterol efflux and fatty
acid oxidation (Rotllan and Ferna´ndez-
Hernando, 2012). Moreover, whether
DICER1 degradation affects the
pathology of cutaneous and mucocuta-
neous leishmaniasis by tampering with
miRNA pools in dermal cells and macro-
phages is an attractive hypothesis that
deserves attention.
In sum, Ghosh and colleagues convinc-
ingly show that Leishmania donovani
lowers serum cholesterol by hindering
the maturation of miR-122 via cleavage
of DICER1. This GP63-mediated effect
opens very exciting possibilities for inves-
tigating how Leishmania affects the host’s
miRNApool tocausediseaseandpromote
the parasite’s success.Cell Host & Microbe 1REFERENCES
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It is currently unclear at which point during viral replication that RNA genomes are first recognized as nonself
by the immune system. In this issue of Cell Host & Microbe, Weber et al. show that incoming nucleocapsid-
bound genomes are sufficient to bind and activate innate immune sensors.In the constant struggle between patho-
gens and their hosts, the evolution of the
immune system was a critical turning
point. Most vertebrates can mount adap-
tive immune responses in which specific
recognition of the invading microbe often
leads to long-term protection from rein-
fection. In contrast, almost all living
organisms exhibit some form of innate
immunity. The innate immune system
provides a more generic and limited
response to infection and, in vertebrates,
serves to augment the subsequent adap-tive response. The effectors of the innate
immune response include many types of
receptors, both membrane bound and
soluble in the cytoplasm and extracellular
milieu, which bind to structural motifs
known as pathogen-associated molec-
ular patterns (PAMPs) (Janeway and
Medzhitov, 2002). One of the more well
studied of these groups of pathogen
recognition receptors (PRRs) is the family
of RIG-I-like proteins, consisting of RIG-I,
MDA5, and LGP2, that recognize viral
PAMPs. Although these molecules haveclosely related sequences and structures,
they recognize PAMPs from different
viruses. For example, MDA5 can interact
with long double-stranded RNA (dsRNA)
and is important for resistance to picorna-
virues (Kato et al., 2006). In contrast, RIG-I
can interact with short dsRNA, as well as
both single- and double-stranded RNA
containing a 50 triphosphate (50 PPP)
group, and is critical for the response to
infection by influenza and other negative
sense single-stranded RNA viruses (Kato
et al., 2006). Ligand-receptor binding3, March 13, 2013 ª2013 Elsevier Inc. 247
Figure 1. Nature and Availability of RIG-I Ligands during the Virus Replication Cycle
Encapsidated viral RNAwith 50 PPP groups and proper secondary structures for RIG-I recognition are relatively few in number shortly after virus entry. The coated
viral RNA (vRNA) interacts with the C-terminal domain of RIG-I to allow activation of RIG-I and association with IPS-1 present on peroxisomes to initiate ISGs
mediated early antiviral response. vRNA is replicated and transcribed in the nucleus (in the case of influenza A virus, illustrated here) or in the cytoplasm
(many other RNA viruses) to produce abundant messenger RNA (mRNA) (coated or capped?) and vRNA with 50 PPP (coated?) available for optimal RIG-I
activation and IFN production via IPS interaction present on mitochondria. Although RIG-I can be activated by either naked or encapsidated viral RNA, whether
the different ligands induce similar or different structural rearrangements (‘‘X’’ or ‘‘Y’’ conformation) is not clear.
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Previewsinduces a conformational change that
facilitates interactions between the PRR
and downstream signaling molecules
(Figure 1) (Cui et al., 2008). These binding
partners act as scaffolds to assemble
large complexes at internal organelle
membranes. Current evidence suggests
that the location of the assembled
complexes plays an important role in the
cellular response. In the case of RIG-I
and the downstream adaptor protein
IPS-1 (also referred to as MAVS, VISA,
and Cardiff), an interaction has been de-
tected at both peroxisomes and mito-
chondria (Dixit et al., 2010). Signaling
from the mitochondrial location leads to
activation of numerous transcription
factors necessary for expression of inter-
feron-beta (IFN-b). After secretion, IFN-b
binds to its receptor at the cell surface
and activates the expression of inter-
feron-stimulated genes (ISGs) in both an
autocrine and paracrine manner. Binding
of RIG-I and IPS-1 at peroxisomes yields
a faster response by directly activating
select ISGs independent of interferon248 Cell Host & Microbe 13, March 13, 2013production (Dixit et al., 2010). The net
result of signaling from these organelle
membranes is the production of an anti-
viral state in both the infected and in the
surrounding cells (Figure 1).
To initiate these complex signaling
pathways, RIG-I must sense the presence
of an invading virus and bind to the recog-
nized PAMP. The RNA viruses that RIG-I
responds to synthesize their genomes
with RNA-dependent RNA polymerases
(RdRps) (Makeyev and Bamford, 2001).
Unlike DNA polymerases, most RdRps
do not need a primer to initiate synthesis,
resulting in transcripts that are initiated by
a 50 PPP group. The requirements for
RIG-I binding to synthetic ligands con-
taining 50 PPP have been dissected
extensively under carefully controlled
conditions. Mutagenesis of synthetic
ligands followed by transfection into cells
and observation of RIG-I activation has
provided great insight into the minimal
requirements necessary for the induction
of innate immunity (Hornung et al., 2006;
Pichlmair et al., 2006; Davis et al., 2012).ª2013 Elsevier Inc.In addition, structural analyses of RIG-I
bound to cognate substrates have yielded
information about critical contacts
between ligand and receptor and led to
models of possible mechanisms of RIG-I
activation. However, much less is known
about the nature of the authentic sub-
strate for RIG-I during an actual infection.
For instance, influenza A virus packages
eight genomic segments containing 50
PPP. Although these RNA molecules
should be ideal substrates for RIG-I,
many studies indicate that viral replication
is a requirement for a robust RIG-I-medi-
ated immune response (Rehwinkel et al.,
2010). An explanation for these findings
has not yet been determined, but possibil-
ities include that early during infection
available targets are much less abundant
and that nucleocapsid proteins bound to
the viral genome interfere with RIG-I
access. Now, in this issue of Cell Host &
Microbe, Weber et al. (2013) provide
evidence that suggests that not only are
viral genomes from incoming virions suffi-
cient for induction of the RIG-I-mediated
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Previewsimmune response, but also that these
RIG-I ligands are capable of initiating the
innate response while still bound by
nucleocapsids.
To address these issues, the authors in-
fected cells with a variety of viruses in the
presence of the protein synthesis inhibitor
cycloheximide (CHX). Some of the viruses
used, such as influenza A virus, are able to
transcribe their genomes to generate
primary transcripts but are not able to
accomplish full-genome replication in
the absence of protein synthesis. Others,
such as Rift Valley fever virus, cannot
even complete primary transcription. In
each case, however, innate immune acti-
vation, as indicated by the induction of
ISGs, was observed. That the innate
receptor involved was RIG-I was deter-
mined through several lines of experi-
mentation. First, the ability to induce
interferon in the presence of CHX was
not common to all viruses tested. Only
those exhibiting 50 PPP groups were
able to induce IFN expression in the pres-
ence of CHX. Two viruses without free
50 PPP groups were not able stimulate
interferon production when protein
synthesis was inhibited, suggesting that
the innate response to these viruses is
not signaled through the RIG-I pathway.
Second, abrogation of RIG-I expression,
either through small-interfering-RNA-
mediated knockdown or by use of
knockout cell lines, eliminated the IFN
response. Finally, RIG-I was directly
shown to be activated, based on confor-
mational changes and oligomerization, in
response to the infecting viruses.
To further examine the interaction
between RIG-I and incoming viral
genomes, Weber et al. used immunofluo-
rescence to colocalize nucleocapsids
and RIG-I. Under conditions of arrested
protein synthesis, as well as during full
viral replication, nucleocapsids andRIG-I colocalized to peroxisomes. As
peroxisomes have been shown to be the
site of early immune signaling through
IPS-1(Dixit et al., 2010), these results
support previous evidence of a biphasic
innate immune response and raise the
possibility that signaling at peroxisomes
is stimulated by incoming viral genomes
and later mitochondrial signaling facili-
tated by a higher quantity products of viral
replication. The differences in the compo-
nents of the two signaling platforms at
the distinct cellular locations that allow
this biphasic response remain to be deter-
mined. This colocalization is supported
by coimmunoprecipitation experiments
in which RIG-I and nucleocapsids formed
complexes in both mammalian and insect
cell systems.
This study provides provocative new
evidence that full viral replication is not
necessary for activation of the RIG-I-
mediated arm of the innate immune
system and raises the possibility that
viral nucleocapsid proteins participate
directly in early peroxisome-mediated
signaling events. Although it was shown
with RNase and phosphatase treatments
of the nucleocapsids that the 50 PPP
RNA was essential for RIG-I activation
by nucleocapsids, the need for viral RNA
for the RIG-I/nucleocapsid colocalization
was unclear. The genetic tractability of
the Drosophila cell system has the poten-
tial to provide further insight into host
factors required for the RIG-I/nucleo-
capsid interaction. It will also be of
interest to determine whether or not the
nucleocapsid proteins are required for
the early initiation of peroxisome
signaling. Even if direct interactions
between RIG-I and nucleocapsids do
not take place, nucleocapsids could
function to protect RIG-I ligands long
enough for RIG-I binding and peroxisomal
localization to take place. Answers toCell Host & Microbe 1these remaining questions should further
illuminate the mechanism of essential
immune responses critical for mitigation
of viral infection.ACKNOWLEDGMENTS
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